Seeking Alpha

Pfizer sues Indian company over Viagra

  • Pfizer (PFE) has sued to prevent India's Torrent Pharmaceuticals from selling a generic version of Viagra until the drug's patent expires in October 2019.
  • Pfizer's action comes after Torrent filed to market a copycat form of the product before the patent ends.
  • The stakes are high, as Viagra generated $1.88B in sales last year, or 3.6% of Pfizer's total revenue
  • Pfizer has sued other firms over the same issue and has reached an agreement with Teva (TEVA) that would allow the Israeli company to start selling generic Viagra in December 2017 or earlier under certain circumstances.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs